| Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE) J Xie, S Reverdatto, A Frolov, R Hoffmann, DS Burz, A Shekhtman Journal of Biological Chemistry 283 (40), 27255-27269, 2008 | 231 | 2008 |
| Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches J Xie, DS Burz, W He, IB Bronstein, I Lednev, A Shekhtman Journal of Biological Chemistry 282 (6), 4218-4231, 2007 | 196 | 2007 |
| In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide Y Ji, S Majumder, M Millard, R Borra, T Bi, AY Elnagar, N Neamati, ... Journal of the American Chemical Society 135 (31), 11623-11633, 2013 | 191 | 2013 |
| Advanced glycation end product recognition by the receptor for AGEs J Xue, V Rai, D Singer, S Chabierski, J Xie, S Reverdatto, DS Burz, ... Structure 19 (5), 722-732, 2011 | 178 | 2011 |
| Semisynthesis of a segmental isotopically labeled protein splicing precursor: NMR evidence for an unusual peptide bond at the N-extein–intein junction A Romanelli, A Shekhtman, D Cowburn, TW Muir Proceedings of the National Academy of Sciences 101 (17), 6397-6402, 2004 | 177 | 2004 |
| Mapping structural interactions using in-cell NMR spectroscopy (STINT-NMR) DS Burz, K Dutta, D Cowburn, A Shekhtman Nature methods 3 (2), 91-93, 2006 | 176 | 2006 |
| A novel, specific interaction involving the Csk SH3 domain and its natural ligand R Ghose, A Shekhtman, MJ Goger, H Ji, D Cowburn Nature structural biology 8 (11), 998-1004, 2001 | 165 | 2001 |
| Autoregulation of a bacterial σ factor explored by using segmental isotopic labeling and NMR JA Camarero, A Shekhtman, EA Campbell, M Chlenov, TM Gruber, ... Proceedings of the National Academy of Sciences 99 (13), 8536-8541, 2002 | 145 | 2002 |
| Both Ca 2+ and Zn 2+ are essential for S100A12 protein oligomerization and function OV Moroz, W Burkitt, H Wittkowski, W He, A Ianoul, V Novitskaya, J Xie, ... BMC biochemistry 10 (1), 1-18, 2009 | 119 | 2009 |
| Biosynthesis of a fully functional cyclotide inside living bacterial cells JA Camarero, RH Kimura, YH Woo, A Shekhtman, J Cantor Chembiochem 8 (12), 1363-1366, 2007 | 119 | 2007 |
| Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity TL Aboye, H Ha, S Majumder, F Christ, Z Debyser, A Shekhtman, ... Journal of medicinal chemistry 55 (23), 10729-10734, 2012 | 108 | 2012 |
| The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs J Xue, R Ray, D Singer, D Böhme, DS Burz, V Rai, R Hoffmann, ... Biochemistry 53 (20), 3327-3335, 2014 | 103 | 2014 |
| Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI‐I J Austin, W Wang, S Puttamadappa, A Shekhtman, JA Camarero Chembiochem 10 (16), 2663-2670, 2009 | 94 | 2009 |
| Signal Transduction in Receptor for Advanced Glycation End Products (RAGE) V Rai, AY Maldonado, DS Burz, S Reverdatto, AM Schmidt, A Shekhtman Journal of Biological Chemistry 287 (7), 5133-5144, 2012 | 93 | 2012 |
| In-cell NMR for protein-protein interactions (STINT-NMR) DS Burz, K Dutta, D Cowburn, A Shekhtman Nature protocols 1 (1), 146, 2006 | 88 | 2006 |
| A ubiquitin-interacting motif from Hrs binds to and occludes the ubiquitin surface necessary for polyubiquitination in monoubiquitinated proteins A Shekhtman, D Cowburn Biochemical and biophysical research communications 296 (5), 1222-1227, 2002 | 86 | 2002 |
| Peptide aptamers: development and applications S Reverdatto, DS Burz, A Shekhtman Current topics in medicinal chemistry 15 (12), 1082, 2015 | 83 | 2015 |
| Structure of proteins in eukaryotic compartments K Bertrand, S Reverdatto, DS Burz, R Zitomer, A Shekhtman Journal of the American Chemical Society 134 (30), 12798-12806, 2012 | 75 | 2012 |
| Screening of small molecule interactor library by using in-cell NMR spectroscopy (SMILI-NMR) J Xie, R Thapa, S Reverdatto, DS Burz, A Shekhtman Journal of medicinal chemistry 52 (11), 3516-3522, 2009 | 74 | 2009 |
| The multiple faces of RAGE–opportunities for therapeutic intervention in aging and chronic disease R Ramasamy, A Shekhtman, AM Schmidt Expert opinion on therapeutic targets 20 (4), 431-446, 2016 | 73 | 2016 |
Julio A. CamareroProfessor of Pharmacology and Chemistry, University of Southern CaliforniaVerified email at usc.edu
